Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Coagulation Factor Concentrates Market Growth 2022-2028

  • LP 4793514
  • 107 Pages
  • January 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Coagulation Factor Concentrates will have significant change from previous year. According to our (LP Information) latest study, the global Coagulation Factor Concentrates market size is USD million in 2022 from USD 6320.6 million in 2021, with a change of % between 2021 and 2022. The global Coagulation Factor Concentrates market size will reach USD 9671.9 million in 2028, growing at a CAGR of 6.3% over the analysis period.

The United States Coagulation Factor Concentrates market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Coagulation Factor Concentrates market, reaching US$ million by the year 2028. As for the Europe Coagulation Factor Concentrates landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Coagulation Factor Concentrates players cover CSL (Australia), Grifols (Spain), Shire (Ireland), and Octapharma (Switzerland), etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Coagulation Factor Concentrates market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

Factor VIII

Factor IX

Von Willebrand Factor

Prothrombin Complex Concentrates

Fibrinogen Concentrates

Factor XIII

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Neurology

Immunology

Hematology

Critical Care

Pulmonology

Hemato-Oncology

Rheumatology

Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

CSL (Australia)

Grifols (Spain)

Shire (Ireland)

Octapharma (Switzerland)

Kedrion (Italy)

Bio Product Laboratory (UK)

Sanquin (Netherlands)

LFB (France)

Biotest (Germany)

Japan Blood Products Organization, China Biologic Products (China)

Green Cross Corporation (South Korea)

Shanghai RAAS Blood Products (China)

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Coagulation Factor Concentrates Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Coagulation Factor Concentrates by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Coagulation Factor Concentrates by Country/Region, 2017, 2022 & 2028

2.2 Coagulation Factor Concentrates Segment by Type

2.2.1 Factor VIII

2.2.2 Factor IX

2.2.3 Von Willebrand Factor

2.2.4 Prothrombin Complex Concentrates

2.2.5 Fibrinogen Concentrates

2.2.6 Factor XIII

2.3 Coagulation Factor Concentrates Sales by Type

2.3.1 Global Coagulation Factor Concentrates Sales Market Share by Type (2017-2022)

2.3.2 Global Coagulation Factor Concentrates Revenue and Market Share by Type (2017-2022)

2.3.3 Global Coagulation Factor Concentrates Sale Price by Type (2017-2022)

2.4 Coagulation Factor Concentrates Segment by Application

2.4.1 Neurology

2.4.2 Immunology

2.4.3 Hematology

2.4.4 Critical Care

2.4.5 Pulmonology

2.4.6 Hemato-Oncology

2.4.7 Rheumatology

2.4.8 Others

2.5 Coagulation Factor Concentrates Sales by Application

2.5.1 Global Coagulation Factor Concentrates Sale Market Share by Application (2017-2022)

2.5.2 Global Coagulation Factor Concentrates Revenue and Market Share by Application (2017-2022)

2.5.3 Global Coagulation Factor Concentrates Sale Price by Application (2017-2022)

3 Global Coagulation Factor Concentrates by Company

3.1 Global Coagulation Factor Concentrates Breakdown Data by Company

3.1.1 Global Coagulation Factor Concentrates Annual Sales by Company (2020-2022)

3.1.2 Global Coagulation Factor Concentrates Sales Market Share by Company (2020-2022)

3.2 Global Coagulation Factor Concentrates Annual Revenue by Company (2020-2022)

3.2.1 Global Coagulation Factor Concentrates Revenue by Company (2020-2022)

3.2.2 Global Coagulation Factor Concentrates Revenue Market Share by Company (2020-2022)

3.3 Global Coagulation Factor Concentrates Sale Price by Company

3.4 Key Manufacturers Coagulation Factor Concentrates Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Coagulation Factor Concentrates Product Location Distribution

3.4.2 Players Coagulation Factor Concentrates Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Coagulation Factor Concentrates by Geographic Region

4.1 World Historic Coagulation Factor Concentrates Market Size by Geographic Region (2017-2022)

4.1.1 Global Coagulation Factor Concentrates Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Coagulation Factor Concentrates Annual Revenue by Geographic Region

4.2 World Historic Coagulation Factor Concentrates Market Size by Country/Region (2017-2022)

4.2.1 Global Coagulation Factor Concentrates Annual Sales by Country/Region (2017-2022)

4.2.2 Global Coagulation Factor Concentrates Annual Revenue by Country/Region

4.3 Americas Coagulation Factor Concentrates Sales Growth

4.4 APAC Coagulation Factor Concentrates Sales Growth

4.5 Europe Coagulation Factor Concentrates Sales Growth

4.6 Middle East & Africa Coagulation Factor Concentrates Sales Growth

5 Americas

5.1 Americas Coagulation Factor Concentrates Sales by Country

5.1.1 Americas Coagulation Factor Concentrates Sales by Country (2017-2022)

5.1.2 Americas Coagulation Factor Concentrates Revenue by Country (2017-2022)

5.2 Americas Coagulation Factor Concentrates Sales by Type

5.3 Americas Coagulation Factor Concentrates Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Coagulation Factor Concentrates Sales by Region

6.1.1 APAC Coagulation Factor Concentrates Sales by Region (2017-2022)

6.1.2 APAC Coagulation Factor Concentrates Revenue by Region (2017-2022)

6.2 APAC Coagulation Factor Concentrates Sales by Type

6.3 APAC Coagulation Factor Concentrates Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Coagulation Factor Concentrates by Country

7.1.1 Europe Coagulation Factor Concentrates Sales by Country (2017-2022)

7.1.2 Europe Coagulation Factor Concentrates Revenue by Country (2017-2022)

7.2 Europe Coagulation Factor Concentrates Sales by Type

7.3 Europe Coagulation Factor Concentrates Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Coagulation Factor Concentrates by Country

8.1.1 Middle East & Africa Coagulation Factor Concentrates Sales by Country (2017-2022)

8.1.2 Middle East & Africa Coagulation Factor Concentrates Revenue by Country (2017-2022)

8.2 Middle East & Africa Coagulation Factor Concentrates Sales by Type

8.3 Middle East & Africa Coagulation Factor Concentrates Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Coagulation Factor Concentrates

10.3 Manufacturing Process Analysis of Coagulation Factor Concentrates

10.4 Industry Chain Structure of Coagulation Factor Concentrates

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Coagulation Factor Concentrates Distributors

11.3 Coagulation Factor Concentrates Customer

12 World Forecast Review for Coagulation Factor Concentrates by Geographic Region

12.1 Global Coagulation Factor Concentrates Market Size Forecast by Region

12.1.1 Global Coagulation Factor Concentrates Forecast by Region (2023-2028)

12.1.2 Global Coagulation Factor Concentrates Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Coagulation Factor Concentrates Forecast by Type

12.7 Global Coagulation Factor Concentrates Forecast by Application

13 Key Players Analysis

13.1 CSL (Australia)

13.1.1 CSL (Australia) Company Information

13.1.2 CSL (Australia) Coagulation Factor Concentrates Product Offered

13.1.3 CSL (Australia) Coagulation Factor Concentrates Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 CSL (Australia) Main Business Overview

13.1.5 CSL (Australia) Latest Developments

13.2 Grifols (Spain)

13.2.1 Grifols (Spain) Company Information

13.2.2 Grifols (Spain) Coagulation Factor Concentrates Product Offered

13.2.3 Grifols (Spain) Coagulation Factor Concentrates Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Grifols (Spain) Main Business Overview

13.2.5 Grifols (Spain) Latest Developments

13.3 Shire (Ireland)

13.3.1 Shire (Ireland) Company Information

13.3.2 Shire (Ireland) Coagulation Factor Concentrates Product Offered

13.3.3 Shire (Ireland) Coagulation Factor Concentrates Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Shire (Ireland) Main Business Overview

13.3.5 Shire (Ireland) Latest Developments

13.4 Octapharma (Switzerland)

13.4.1 Octapharma (Switzerland) Company Information

13.4.2 Octapharma (Switzerland) Coagulation Factor Concentrates Product Offered

13.4.3 Octapharma (Switzerland) Coagulation Factor Concentrates Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Octapharma (Switzerland) Main Business Overview

13.4.5 Octapharma (Switzerland) Latest Developments

13.5 Kedrion (Italy)

13.5.1 Kedrion (Italy) Company Information

13.5.2 Kedrion (Italy) Coagulation Factor Concentrates Product Offered

13.5.3 Kedrion (Italy) Coagulation Factor Concentrates Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Kedrion (Italy) Main Business Overview

13.5.5 Kedrion (Italy) Latest Developments

13.6 Bio Product Laboratory (UK)

13.6.1 Bio Product Laboratory (UK) Company Information

13.6.2 Bio Product Laboratory (UK) Coagulation Factor Concentrates Product Offered

13.6.3 Bio Product Laboratory (UK) Coagulation Factor Concentrates Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Bio Product Laboratory (UK) Main Business Overview

13.6.5 Bio Product Laboratory (UK) Latest Developments

13.7 Sanquin (Netherlands)

13.7.1 Sanquin (Netherlands) Company Information

13.7.2 Sanquin (Netherlands) Coagulation Factor Concentrates Product Offered

13.7.3 Sanquin (Netherlands) Coagulation Factor Concentrates Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Sanquin (Netherlands) Main Business Overview

13.7.5 Sanquin (Netherlands) Latest Developments

13.8 LFB (France)

13.8.1 LFB (France) Company Information

13.8.2 LFB (France) Coagulation Factor Concentrates Product Offered

13.8.3 LFB (France) Coagulation Factor Concentrates Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 LFB (France) Main Business Overview

13.8.5 LFB (France) Latest Developments

13.9 Biotest (Germany)

13.9.1 Biotest (Germany) Company Information

13.9.2 Biotest (Germany) Coagulation Factor Concentrates Product Offered

13.9.3 Biotest (Germany) Coagulation Factor Concentrates Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Biotest (Germany) Main Business Overview

13.9.5 Biotest (Germany) Latest Developments

13.10 Japan Blood Products Organization, China Biologic Products (China)

13.10.1 Japan Blood Products Organization, China Biologic Products (China) Company Information

13.10.2 Japan Blood Products Organization, China Biologic Products (China) Coagulation Factor Concentrates Product Offered

13.10.3 Japan Blood Products Organization, China Biologic Products (China) Coagulation Factor Concentrates Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Japan Blood Products Organization, China Biologic Products (China) Main Business Overview

13.10.5 Japan Blood Products Organization, China Biologic Products (China) Latest Developments

13.11 Green Cross Corporation (South Korea)

13.11.1 Green Cross Corporation (South Korea) Company Information

13.11.2 Green Cross Corporation (South Korea) Coagulation Factor Concentrates Product Offered

13.11.3 Green Cross Corporation (South Korea) Coagulation Factor Concentrates Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Green Cross Corporation (South Korea) Main Business Overview

13.11.5 Green Cross Corporation (South Korea) Latest Developments

13.12 Shanghai RAAS Blood Products (China)

13.12.1 Shanghai RAAS Blood Products (China) Company Information

13.12.2 Shanghai RAAS Blood Products (China) Coagulation Factor Concentrates Product Offered

13.12.3 Shanghai RAAS Blood Products (China) Coagulation Factor Concentrates Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Shanghai RAAS Blood Products (China) Main Business Overview

13.12.5 Shanghai RAAS Blood Products (China) Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Coagulation Factor Concentrates Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Coagulation Factor Concentrates Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Factor VIII

Table 4. Major Players of Factor IX

Table 5. Major Players of Von Willebrand Factor

Table 6. Major Players of Prothrombin Complex Concentrates

Table 7. Major Players of Fibrinogen Concentrates

Table 8. Major Players of Factor XIII

Table 9. Global Coagulation Factor Concentrates Sales by Type (2017-2022) & (K Pcs)

Table 10. Global Coagulation Factor Concentrates Sales Market Share by Type (2017-2022)

Table 11. Global Coagulation Factor Concentrates Revenue by Type (2017-2022) & ($ million)

Table 12. Global Coagulation Factor Concentrates Revenue Market Share by Type (2017-2022)

Table 13. Global Coagulation Factor Concentrates Sale Price by Type (2017-2022) & (USD/Pcs)

Table 14. Global Coagulation Factor Concentrates Sales by Application (2017-2022) & (K Pcs)

Table 15. Global Coagulation Factor Concentrates Sales Market Share by Application (2017-2022)

Table 16. Global Coagulation Factor Concentrates Revenue by Application (2017-2022)

Table 17. Global Coagulation Factor Concentrates Revenue Market Share by Application (2017-2022)

Table 18. Global Coagulation Factor Concentrates Sale Price by Application (2017-2022) & (USD/Pcs)

Table 19. Global Coagulation Factor Concentrates Sales by Company (2020-2022) & (K Pcs)

Table 20. Global Coagulation Factor Concentrates Sales Market Share by Company (2020-2022)

Table 21. Global Coagulation Factor Concentrates Revenue by Company (2020-2022) ($ Millions)

Table 22. Global Coagulation Factor Concentrates Revenue Market Share by Company (2020-2022)

Table 23. Global Coagulation Factor Concentrates Sale Price by Company (2020-2022) & (USD/Pcs)

Table 24. Key Manufacturers Coagulation Factor Concentrates Producing Area Distribution and Sales Area

Table 25. Players Coagulation Factor Concentrates Products Offered

Table 26. Coagulation Factor Concentrates Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 27. New Products and Potential Entrants

Table 28. Mergers & Acquisitions, Expansion

Table 29. Global Coagulation Factor Concentrates Sales by Geographic Region (2017-2022) & (K Pcs)

Table 30. Global Coagulation Factor Concentrates Sales Market Share Geographic Region (2017-2022)

Table 31. Global Coagulation Factor Concentrates Revenue by Geographic Region (2017-2022) & ($ millions)

Table 32. Global Coagulation Factor Concentrates Revenue Market Share by Geographic Region (2017-2022)

Table 33. Global Coagulation Factor Concentrates Sales by Country/Region (2017-2022) & (K Pcs)

Table 34. Global Coagulation Factor Concentrates Sales Market Share by Country/Region (2017-2022)

Table 35. Global Coagulation Factor Concentrates Revenue by Country/Region (2017-2022) & ($ millions)

Table 36. Global Coagulation Factor Concentrates Revenue Market Share by Country/Region (2017-2022)

Table 37. Americas Coagulation Factor Concentrates Sales by Country (2017-2022) & (K Pcs)

Table 38. Americas Coagulation Factor Concentrates Sales Market Share by Country (2017-2022)

Table 39. Americas Coagulation Factor Concentrates Revenue by Country (2017-2022) & ($ Millions)

Table 40. Americas Coagulation Factor Concentrates Revenue Market Share by Country (2017-2022)

Table 41. Americas Coagulation Factor Concentrates Sales by Type (2017-2022) & (K Pcs)

Table 42. Americas Coagulation Factor Concentrates Sales Market Share by Type (2017-2022)

Table 43. Americas Coagulation Factor Concentrates Sales by Application (2017-2022) & (K Pcs)

Table 44. Americas Coagulation Factor Concentrates Sales Market Share by Application (2017-2022)

Table 45. APAC Coagulation Factor Concentrates Sales by Region (2017-2022) & (K Pcs)

Table 46. APAC Coagulation Factor Concentrates Sales Market Share by Region (2017-2022)

Table 47. APAC Coagulation Factor Concentrates Revenue by Region (2017-2022) & ($ Millions)

Table 48. APAC Coagulation Factor Concentrates Revenue Market Share by Region (2017-2022)

Table 49. APAC Coagulation Factor Concentrates Sales by Type (2017-2022) & (K Pcs)

Table 50. APAC Coagulation Factor Concentrates Sales Market Share by Type (2017-2022)

Table 51. APAC Coagulation Factor Concentrates Sales by Application (2017-2022) & (K Pcs)

Table 52. APAC Coagulation Factor Concentrates Sales Market Share by Application (2017-2022)

Table 53. Europe Coagulation Factor Concentrates Sales by Country (2017-2022) & (K Pcs)

Table 54. Europe Coagulation Factor Concentrates Sales Market Share by Country (2017-2022)

Table 55. Europe Coagulation Factor Concentrates Revenue by Country (2017-2022) & ($ Millions)

Table 56. Europe Coagulation Factor Concentrates Revenue Market Share by Country (2017-2022)

Table 57. Europe Coagulation Factor Concentrates Sales by Type (2017-2022) & (K Pcs)

Table 58. Europe Coagulation Factor Concentrates Sales Market Share by Type (2017-2022)

Table 59. Europe Coagulation Factor Concentrates Sales by Application (2017-2022) & (K Pcs)

Table 60. Europe Coagulation Factor Concentrates Sales Market Share by Application (2017-2022)

Table 61. Middle East & Africa Coagulation Factor Concentrates Sales by Country (2017-2022) & (K Pcs)

Table 62. Middle East & Africa Coagulation Factor Concentrates Sales Market Share by Country (2017-2022)

Table 63. Middle East & Africa Coagulation Factor Concentrates Revenue by Country (2017-2022) & ($ Millions)

Table 64. Middle East & Africa Coagulation Factor Concentrates Revenue Market Share by Country (2017-2022)

Table 65. Middle East & Africa Coagulation Factor Concentrates Sales by Type (2017-2022) & (K Pcs)

Table 66. Middle East & Africa Coagulation Factor Concentrates Sales Market Share by Type (2017-2022)

Table 67. Middle East & Africa Coagulation Factor Concentrates Sales by Application (2017-2022) & (K Pcs)

Table 68. Middle East & Africa Coagulation Factor Concentrates Sales Market Share by Application (2017-2022)

Table 69. Key Market Drivers & Growth Opportunities of Coagulation Factor Concentrates

Table 70. Key Market Challenges & Risks of Coagulation Factor Concentrates

Table 71. Key Industry Trends of Coagulation Factor Concentrates

Table 72. Coagulation Factor Concentrates Raw Material

Table 73. Key Suppliers of Raw Materials

Table 74. Coagulation Factor Concentrates Distributors List

Table 75. Coagulation Factor Concentrates Customer List

Table 76. Global Coagulation Factor Concentrates Sales Forecast by Region (2023-2028) & (K Pcs)

Table 77. Global Coagulation Factor Concentrates Sales Market Forecast by Region

Table 78. Global Coagulation Factor Concentrates Revenue Forecast by Region (2023-2028) & ($ millions)

Table 79. Global Coagulation Factor Concentrates Revenue Market Share Forecast by Region (2023-2028)

Table 80. Americas Coagulation Factor Concentrates Sales Forecast by Country (2023-2028) & (K Pcs)

Table 81. Americas Coagulation Factor Concentrates Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. APAC Coagulation Factor Concentrates Sales Forecast by Region (2023-2028) & (K Pcs)

Table 83. APAC Coagulation Factor Concentrates Revenue Forecast by Region (2023-2028) & ($ millions)

Table 84. Europe Coagulation Factor Concentrates Sales Forecast by Country (2023-2028) & (K Pcs)

Table 85. Europe Coagulation Factor Concentrates Revenue Forecast by Country (2023-2028) & ($ millions)

Table 86. Middle East & Africa Coagulation Factor Concentrates Sales Forecast by Country (2023-2028) & (K Pcs)

Table 87. Middle East & Africa Coagulation Factor Concentrates Revenue Forecast by Country (2023-2028) & ($ millions)

Table 88. Global Coagulation Factor Concentrates Sales Forecast by Type (2023-2028) & (K Pcs)

Table 89. Global Coagulation Factor Concentrates Sales Market Share Forecast by Type (2023-2028)

Table 90. Global Coagulation Factor Concentrates Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 91. Global Coagulation Factor Concentrates Revenue Market Share Forecast by Type (2023-2028)

Table 92. Global Coagulation Factor Concentrates Sales Forecast by Application (2023-2028) & (K Pcs)

Table 93. Global Coagulation Factor Concentrates Sales Market Share Forecast by Application (2023-2028)

Table 94. Global Coagulation Factor Concentrates Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 95. Global Coagulation Factor Concentrates Revenue Market Share Forecast by Application (2023-2028)

Table 96. CSL (Australia) Basic Information, Coagulation Factor Concentrates Manufacturing Base, Sales Area and Its Competitors

Table 97. CSL (Australia) Coagulation Factor Concentrates Product Offered

Table 98. CSL (Australia) Coagulation Factor Concentrates Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 99. CSL (Australia) Main Business

Table 100. CSL (Australia) Latest Developments

Table 101. Grifols (Spain) Basic Information, Coagulation Factor Concentrates Manufacturing Base, Sales Area and Its Competitors

Table 102. Grifols (Spain) Coagulation Factor Concentrates Product Offered

Table 103. Grifols (Spain) Coagulation Factor Concentrates Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 104. Grifols (Spain) Main Business

Table 105. Grifols (Spain) Latest Developments

Table 106. Shire (Ireland) Basic Information, Coagulation Factor Concentrates Manufacturing Base, Sales Area and Its Competitors

Table 107. Shire (Ireland) Coagulation Factor Concentrates Product Offered

Table 108. Shire (Ireland) Coagulation Factor Concentrates Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 109. Shire (Ireland) Main Business

Table 110. Shire (Ireland) Latest Developments

Table 111. Octapharma (Switzerland) Basic Information, Coagulation Factor Concentrates Manufacturing Base, Sales Area and Its Competitors

Table 112. Octapharma (Switzerland) Coagulation Factor Concentrates Product Offered

Table 113. Octapharma (Switzerland) Coagulation Factor Concentrates Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 114. Octapharma (Switzerland) Main Business

Table 115. Octapharma (Switzerland) Latest Developments

Table 116. Kedrion (Italy) Basic Information, Coagulation Factor Concentrates Manufacturing Base, Sales Area and Its Competitors

Table 117. Kedrion (Italy) Coagulation Factor Concentrates Product Offered

Table 118. Kedrion (Italy) Coagulation Factor Concentrates Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 119. Kedrion (Italy) Main Business

Table 120. Kedrion (Italy) Latest Developments

Table 121. Bio Product Laboratory (UK) Basic Information, Coagulation Factor Concentrates Manufacturing Base, Sales Area and Its Competitors

Table 122. Bio Product Laboratory (UK) Coagulation Factor Concentrates Product Offered

Table 123. Bio Product Laboratory (UK) Coagulation Factor Concentrates Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 124. Bio Product Laboratory (UK) Main Business

Table 125. Bio Product Laboratory (UK) Latest Developments

Table 126. Sanquin (Netherlands) Basic Information, Coagulation Factor Concentrates Manufacturing Base, Sales Area and Its Competitors

Table 127. Sanquin (Netherlands) Coagulation Factor Concentrates Product Offered

Table 128. Sanquin (Netherlands) Coagulation Factor Concentrates Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 129. Sanquin (Netherlands) Main Business

Table 130. Sanquin (Netherlands) Latest Developments

Table 131. LFB (France) Basic Information, Coagulation Factor Concentrates Manufacturing Base, Sales Area and Its Competitors

Table 132. LFB (France) Coagulation Factor Concentrates Product Offered

Table 133. LFB (France) Coagulation Factor Concentrates Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 134. LFB (France) Main Business

Table 135. LFB (France) Latest Developments

Table 136. Biotest (Germany) Basic Information, Coagulation Factor Concentrates Manufacturing Base, Sales Area and Its Competitors

Table 137. Biotest (Germany) Coagulation Factor Concentrates Product Offered

Table 138. Biotest (Germany) Coagulation Factor Concentrates Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 139. Biotest (Germany) Main Business

Table 140. Biotest (Germany) Latest Developments

Table 141. Japan Blood Products Organization, China Biologic Products (China) Basic Information, Coagulation Factor Concentrates Manufacturing Base, Sales Area and Its Competitors

Table 142. Japan Blood Products Organization, China Biologic Products (China) Coagulation Factor Concentrates Product Offered

Table 143. Japan Blood Products Organization, China Biologic Products (China) Coagulation Factor Concentrates Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 144. Japan Blood Products Organization, China Biologic Products (China) Main Business

Table 145. Japan Blood Products Organization, China Biologic Products (China) Latest Developments

Table 146. Green Cross Corporation (South Korea) Basic Information, Coagulation Factor Concentrates Manufacturing Base, Sales Area and Its Competitors

Table 147. Green Cross Corporation (South Korea) Coagulation Factor Concentrates Product Offered

Table 148. Green Cross Corporation (South Korea) Coagulation Factor Concentrates Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 149. Green Cross Corporation (South Korea) Main Business

Table 150. Green Cross Corporation (South Korea) Latest Developments

Table 151. Shanghai RAAS Blood Products (China) Basic Information, Coagulation Factor Concentrates Manufacturing Base, Sales Area and Its Competitors

Table 152. Shanghai RAAS Blood Products (China) Coagulation Factor Concentrates Product Offered

Table 153. Shanghai RAAS Blood Products (China) Coagulation Factor Concentrates Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 154. Shanghai RAAS Blood Products (China) Main Business

Table 155. Shanghai RAAS Blood Products (China) Latest Developments

List of Figures

Figure 1. Picture of Coagulation Factor Concentrates

Figure 2. Coagulation Factor Concentrates Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Coagulation Factor Concentrates Sales Growth Rate 2017-2028 (K Pcs)

Figure 7. Global Coagulation Factor Concentrates Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Coagulation Factor Concentrates Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Factor VIII

Figure 10. Product Picture of Factor IX

Figure 11. Product Picture of Von Willebrand Factor

Figure 12. Product Picture of Prothrombin Complex Concentrates

Figure 13. Product Picture of Fibrinogen Concentrates

Figure 14. Product Picture of Factor XIII

Figure 15. Global Coagulation Factor Concentrates Sales Market Share by Type in 2021

Figure 16. Global Coagulation Factor Concentrates Revenue Market Share by Type (2017-2022)

Figure 17. Coagulation Factor Concentrates Consumed in Neurology

Figure 18. Global Coagulation Factor Concentrates Market: Neurology (2017-2022) & (K Pcs)

Figure 19. Coagulation Factor Concentrates Consumed in Immunology

Figure 20. Global Coagulation Factor Concentrates Market: Immunology (2017-2022) & (K Pcs)

Figure 21. Coagulation Factor Concentrates Consumed in Hematology

Figure 22. Global Coagulation Factor Concentrates Market: Hematology (2017-2022) & (K Pcs)

Figure 23. Coagulation Factor Concentrates Consumed in Critical Care

Figure 24. Global Coagulation Factor Concentrates Market: Critical Care (2017-2022) & (K Pcs)

Figure 25. Coagulation Factor Concentrates Consumed in Pulmonology

Figure 26. Global Coagulation Factor Concentrates Market: Pulmonology (2017-2022) & (K Pcs)

Figure 27. Coagulation Factor Concentrates Consumed in Hemato-Oncology

Figure 28. Global Coagulation Factor Concentrates Market: Hemato-Oncology (2017-2022) & (K Pcs)

Figure 29. Coagulation Factor Concentrates Consumed in Rheumatology

Figure 30. Global Coagulation Factor Concentrates Market: Rheumatology (2017-2022) & (K Pcs)

Figure 31. Coagulation Factor Concentrates Consumed in Others

Figure 32. Global Coagulation Factor Concentrates Market: Others (2017-2022) & (K Pcs)

Figure 33. Global Coagulation Factor Concentrates Sales Market Share by Application (2017-2022)

Figure 34. Global Coagulation Factor Concentrates Revenue Market Share by Application in 2021

Figure 35. Coagulation Factor Concentrates Revenue Market by Company in 2021 ($ Million)

Figure 36. Global Coagulation Factor Concentrates Revenue Market Share by Company in 2021

Figure 37. Global Coagulation Factor Concentrates Sales Market Share by Geographic Region (2017-2022)

Figure 38. Global Coagulation Factor Concentrates Revenue Market Share by Geographic Region in 2021

Figure 39. Global Coagulation Factor Concentrates Sales Market Share by Region (2017-2022)

Figure 40. Global Coagulation Factor Concentrates Revenue Market Share by Country/Region in 2021

Figure 41. Americas Coagulation Factor Concentrates Sales 2017-2022 (K Pcs)

Figure 42. Americas Coagulation Factor Concentrates Revenue 2017-2022 ($ Millions)

Figure 43. APAC Coagulation Factor Concentrates Sales 2017-2022 (K Pcs)

Figure 44. APAC Coagulation Factor Concentrates Revenue 2017-2022 ($ Millions)

Figure 45. Europe Coagulation Factor Concentrates Sales 2017-2022 (K Pcs)

Figure 46. Europe Coagulation Factor Concentrates Revenue 2017-2022 ($ Millions)

Figure 47. Middle East & Africa Coagulation Factor Concentrates Sales 2017-2022 (K Pcs)

Figure 48. Middle East & Africa Coagulation Factor Concentrates Revenue 2017-2022 ($ Millions)

Figure 49. Americas Coagulation Factor Concentrates Sales Market Share by Country in 2021

Figure 50. Americas Coagulation Factor Concentrates Revenue Market Share by Country in 2021

Figure 51. United States Coagulation Factor Concentrates Revenue Growth 2017-2022 ($ Millions)

Figure 52. Canada Coagulation Factor Concentrates Revenue Growth 2017-2022 ($ Millions)

Figure 53. Mexico Coagulation Factor Concentrates Revenue Growth 2017-2022 ($ Millions)

Figure 54. Brazil Coagulation Factor Concentrates Revenue Growth 2017-2022 ($ Millions)

Figure 55. APAC Coagulation Factor Concentrates Sales Market Share by Region in 2021

Figure 56. APAC Coagulation Factor Concentrates Revenue Market Share by Regions in 2021

Figure 57. China Coagulation Factor Concentrates Revenue Growth 2017-2022 ($ Millions)

Figure 58. Japan Coagulation Factor Concentrates Revenue Growth 2017-2022 ($ Millions)

Figure 59. South Korea Coagulation Factor Concentrates Revenue Growth 2017-2022 ($ Millions)

Figure 60. Southeast Asia Coagulation Factor Concentrates Revenue Growth 2017-2022 ($ Millions)

Figure 61. India Coagulation Factor Concentrates Revenue Growth 2017-2022 ($ Millions)

Figure 62. Australia Coagulation Factor Concentrates Revenue Growth 2017-2022 ($ Millions)

Figure 63. Europe Coagulation Factor Concentrates Sales Market Share by Country in 2021

Figure 64. Europe Coagulation Factor Concentrates Revenue Market Share by Country in 2021

Figure 65. Germany Coagulation Factor Concentrates Revenue Growth 2017-2022 ($ Millions)

Figure 66. France Coagulation Factor Concentrates Revenue Growth 2017-2022 ($ Millions)

Figure 67. UK Coagulation Factor Concentrates Revenue Growth 2017-2022 ($ Millions)

Figure 68. Italy Coagulation Factor Concentrates Revenue Growth 2017-2022 ($ Millions)

Figure 69. Russia Coagulation Factor Concentrates Revenue Growth 2017-2022 ($ Millions)

Figure 70. Middle East & Africa Coagulation Factor Concentrates Sales Market Share by Country in 2021

Figure 71. Middle East & Africa Coagulation Factor Concentrates Revenue Market Share by Country in 2021

Figure 72. Egypt Coagulation Factor Concentrates Revenue Growth 2017-2022 ($ Millions)

Figure 73. South Africa Coagulation Factor Concentrates Revenue Growth 2017-2022 ($ Millions)

Figure 74. Israel Coagulation Factor Concentrates Revenue Growth 2017-2022 ($ Millions)

Figure 75. Turkey Coagulation Factor Concentrates Revenue Growth 2017-2022 ($ Millions)

Figure 76. GCC Country Coagulation Factor Concentrates Revenue Growth 2017-2022 ($ Millions)

Figure 77. Manufacturing Cost Structure Analysis of Coagulation Factor Concentrates in 2021

Figure 78. Manufacturing Process Analysis of Coagulation Factor Concentrates

Figure 79. Industry Chain Structure of Coagulation Factor Concentrates

Figure 80. Channels of Distribution

Figure 81. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390